Alka Chaubey


Alka Chaubey, CMO, Bionano Genomics

Alka Chaubey is double board-certified in clinical cytogenetics/genomics and clinical molecular genetics/genomics by the American Board of Medical Genetics and Genomics (ABMGG).

Previously, she was the Head of Cytogenomics at PerkinElmer Genomics, where Dr. Chaubey led the successful development and launch of several innovative products including the CNGnome test (low-pass whole genome sequencing), and a new FSHD assay utilizing Saphyr. She has also played an integral role on Vanadis team at PerkinElmer in their efforts to bring a new PCR-free NIPT technology to the market. Prior to PerkinElmer Genomics, Dr. Chaubey was the Director of the Cytogenomics Laboratory at the Greenwood Genetic Center, SC, USA. She also holds an academic appointment as the Scientific Director of the Georgia Esoteric and Molecular Laboratory, Scientific Director of the Cytogenetics Laboratory of the Augusta University Medical Center, and Adjunct Assistant professor of Pathology of the Medical College of Georgia at Augusta University.

Dr. Chaubey serves on the Board of Directors for the Cancer Genomics Consortium and is also the Genetics Subdivision Nominating Committee representative of the Association of Molecular Pathologists (AMP). She originally received her Doctorate degree (PhD) from Guru Nanak Dev University, Amritsar, India, and completed her post-doctoral studies at the Center for Cellular and Molecular Biology (CCMB), Hyderabad, India, and the University of Illinois at Chicago (UIC).

Interview with Alka (published March 2021) https://mendelspod.com/podcasts/future-big-biology-bionano-agbt/

Interview with Alka (published May 2018) https://mendelspod.com/podcasts/has-diagnostic-testing-plateaued-alka-ch...

Interview with Alka (published September 2015) https://mendelspod.com/podcasts/diagnostic-success-story-alka-chaubey-gr...



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup